Company / Depreciation & Amortization
GYRE THERAPEUTICS, INC. Depreciation & Amortization History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Depreciation & Amortization
$2.5M
FY2025
5-year range
$290.0K / $2.5M
FY2021-FY2025
Trend
+60.2%
vs FY2024
Sector context
#95 of 163
Health Care
What the data says
At $2M, GYRE THERAPEUTICS, INC.'s depreciation & amortization ranks #69 of 163 in the Health Care sector. Increased from $1M to $2M over the past 2 years.
Based on SEC 10-K filings.
$2M in FY2025 with a 5-year CAGR of +76.2%.
Increased from $1M to $2M over the past 2 years.
Health Care sector context is included.
Depreciation & Amortization over time
Growth rates
- 3-Year CAGR
- +31.7%
- 5-Year CAGR
- +76.2%
- 10-Year CAGR
- -
Sector benchmark
#69 of 163 in Health CareTop 42% of 163This company $2.5M Sector average $219.4M
▼
-98.9% below sector average
Key checks
Key Insights
- 5-year CAGR of +76.2%, indicating consistent growth.
- In FY2025, depreciation & amortization increased 60.2% year-over-year.
- Ranks #95 out of 163 companies in the Health Care sector.
- Lowest depreciation & amortization in the period was in FY2020.
Company context
Key Data Points
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Depreciation & AmortizationValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $2.5M | +60.2% |
| FY2024 | $1.5M | +42.5% |
| FY2023 | $1.1M | +0.0% |
| FY2022 | $1.1M | +274.8% |
| FY2021 | $290.0K | +98.6% |
| FY2020 | $146.0K | +0.0% |
| FY2019 | $146.0K | -15.6% |
| FY2018 | $173.0K | +0.0% |
| FY2017 | $173.0K | -55.5% |
| FY2016 | $389.0K | -17.2% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026